UK oncology approvals in 2022: global regulatory collaboration and new regulatory pathways deliver new anti-cancer therapies.

Lythgoe MP., Sullivan R., Blagden S.

DOI

10.1016/S1470-2045(23)00218-8

Type

Journal article

Publication Date

2023-09-01T00:00:00+00:00

Volume

24

Pages

963 - 966

Total pages

3

Keywords

Humans, United Kingdom, Medical Oncology, Drug Approval, Antineoplastic Agents

Permalink More information Close